Generic maintenance immunosuppression in solid organ transplant recipients.
about
Simple signaling molecules for inductive bone regenerative engineering.Case report: Inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution.A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipientsA multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients.Immunosuppression and allograft rejection following lung transplantation: evidence to date.Generic tacrolimus in solid organ transplantation.Generic immunosuppression in transplantation: current evidence and controversial issues.Advances in pharmacotherapy to treat kidney transplant rejection.Spinal cord injuries: how could cell therapy help?Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored.Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart transplant patients.The Cost of Transplant Immunosuppressant Therapy: Is This Sustainable?Transplant coordinators' perceived impact of availability of multiple generic immunosuppression therapies on patients, workload, and posttransplant maintenance therapy.Tacrolimus Utilization and Expenditure in Serbia.Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.Evaluation of the Crystallization Tendency of Commercially Available Amorphous Tacrolimus Formulations Exposed to Different Stress Conditions.
P2860
Q30411879-11AE8CE0-18E0-4BE6-A452-68131444217FQ35486822-16AA6F3F-B206-44F3-B8E5-B479624820A4Q36319486-DE401F67-CB69-4395-98A5-1CF502EB5169Q37718547-DFCB50F3-C12A-48F0-B80E-0A62B25317E0Q38154197-F2E29180-7BE4-4986-B573-CA2C49EF7AEBQ38205921-F26B55F3-F21E-473B-9C79-1F742DD784B3Q38393905-3E360D76-5DE3-40C2-B505-1ABB89864B49Q38544529-1A6E7276-C1CD-46B1-A868-5021B593D488Q39183871-ED049C94-296B-417D-8B63-F005B3A29706Q40313782-E02AE216-2F91-49D8-BDEC-9E7ABC4EC8E2Q41733509-34CDD87F-A972-4274-89AF-8E15A2BEF1BBQ41774477-55F76E33-FD6C-4052-B82A-5298CD7EA040Q41888764-77E4A2C6-33F4-40F5-9870-2027D1860B4BQ44809911-C4D2E59F-4872-4882-97AE-DB62F76E0812Q46167705-66D6F8AD-3EEE-44B5-B76C-FE222E3F5E04Q47152860-47518D35-BA2D-47FA-A253-5C01DD834977Q47979527-A35395D4-B58C-4A2B-A0E2-77949612B60A
P2860
Generic maintenance immunosuppression in solid organ transplant recipients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Generic maintenance immunosuppression in solid organ transplant recipients.
@en
Generic maintenance immunosuppression in solid organ transplant recipients.
@nl
type
label
Generic maintenance immunosuppression in solid organ transplant recipients.
@en
Generic maintenance immunosuppression in solid organ transplant recipients.
@nl
prefLabel
Generic maintenance immunosuppression in solid organ transplant recipients.
@en
Generic maintenance immunosuppression in solid organ transplant recipients.
@nl
P2093
P2860
P356
P1433
P1476
Generic maintenance immunosuppression in solid organ transplant recipients.
@en
P2093
Christopher R Ensor
Jennifer Trofe-Clark
Lisa M McDevitt-Potter
Michael A Shullo
P2860
P304
P356
10.1592/PHCO.31.11.1111
P407
P577
2011-11-01T00:00:00Z